Chikungunya is one of the most rapidly spreading Aedes mosquito-borne viral infectious diseases. Recently in Bangladesh it has emerged as an important public health issue. Chikungunya virus (CHIKV) mostly spread by Aedes aegypti and Aedes albopictus, an anthropophilic mosquito species widely distributed in Asia, Europe, Africa and America. Our objective was to determine the clinical, biochemical and radiological features of patients at the acute phase of CHIKV infection. The purpose of study was to evaluate the literature and summarize the current state of CHIKV-associated disease, including clinical presentation, diagnosis, risk factors for development of severe diseases, complications and treatment.
Introduction:
Chikungunya is caused by a vector-borne virus of genous Alphavirus and family Togavirus. Aedes aegypti and Aedes albopictus are the usual vectors, which are also responsible for transmission of dengue, hence there is concurrence or co-incidences of dengue and chikungunya in endemic regions 1 . In Bangladesh, over the past two decades, dengue had been recognized as endemic disease with high incidence during the rainy seasons. Last year's outbreak of chikungunya also parallels the same seasonal and environmental characteristics of dengue in Dhaka, Bangladesh. Aedes albopictus 2 was the main vector in 2011 outbreak in Dhaka. Scientists forecasted chikungunya as an emerging viral infection in Bangladesh in 2014 as well 3 .
Methods :
A retrospective observational study enrolled 253 consecutive patients older than 20 years with fever, arthralgia, rash admitted at the tertiary level hospital situated in gulshan, Dhaka city from March 2017 to November 2017. Biological confirmation of CHIKV infection was obtained for all patients, either by detection of CHIK virus RNA in the blood during acute stage by RT-PCR or the presence of anti-CHIK virus specific immunoglobulin M by ELISA depending on delayed presentation. And dengue was excluded by doing either dengue NS1 on initial presentation or ICT for dengue in late presentation. But those patients who had co-infection of dengue and CHIKV were included in the study. Three groups were defined: first group of 80 viremic patients (positive CHIKV RT-PCR), second group of 173 patients with acute post-viremic infection (positive anti-CHIKV IgM and negative IgG) and last group of 5 patients having both Dengue and chikungunya ( dengue NS1 +ve, Ig M for CHIKV positive or RT-PCR positive for CHIKV). All statistical data were analyzed by SPSS 22 software package. P value <0.05 considered as significant.
Results:
The population was predominantly male (59%) and the median age was 55 years ranging from 20-70 years. Highest recorded number patients were admitted between june'17 to September '17. Patients with CHIKV viremia presented typically with asymmetrical bilateral polyarthralgia (96.5%) affecting the lower limbs (98%) and small joints of hands (74.8%), as well as asthenia (88.6%), headache (70%), nausea,vomiting (63.3%), myalgia (59%), exanthems (47.8%). Vertigo, cutaneous dysesthesia, pharyngitis and haemorrhages were seldom observed. Pruritis was less frequent during the viremic than post-viremic phase (13.9% vs. 41.2%; p<0.001), whereas lymphopenia was more frequent (87.6% vs. 39.4%; p<0.001). Others biological abnormalities included leukopenia (38.3%), thrombocytopenia (37.3%), increased AST and ALT blood levels (31.6 and 37.3%, respectively). Age under 50 were associated with a benign course of the disease. In the rainy season, the highest recorded patients were admitted in hospital from June to September (Fig-1 ) 2017. Among them the rate of middle aged patients admission were common (Fig-2 ) due to their multiple co-morbidities like ischemic heart disease, hypertension, diabetes, osteoarthritis. During hospital stay few patients developed complication related to cardio-respiratory system but subsequent follow up in OPD revealed that most of them i.e 79% patients having post viral arthritis and 34 % patient having asthenia. (Table-1 ). In table 1 there were also showed comparison of complication of CHIKV with dengue patients who were then admitted in hospital. Our study also showed ankle joint involvement was most commonly involved in CHIKV infection. (Table-2 
)

Discussion :
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that circulates predominantly in tropical and subtropical regions, potentially affecting over 1 billion people. "Chikungunya" is a Makonde word in Tanzania meaning "to walk bent over" or "that which bends up" 4 .
One of the most consistent and debilitating manifestations of CHIKV-induced disease in people consists of an often widespread, severe and incapacitating arthralgia, occurring in 85-100% of people with symptomatic infection 5, 6, 7 . In fact, this disease manifestation is so common in CHIKVinduced disease, it has been reported that the presence of concurrent high fever and arthralgia has a specificity of 99.6% and positive predictive value of 84.6% for In most cases these symptoms resolves in approximately 2 weeks 9 . However, as many as 88% of people can have arthralgia persisting for 1 month after the initial symptoms 10, 11 . In our study, 79 % patients having post viral arthalgia which is consistent with this study.
Arthralgia associated with CHIKV infection is often considered to be the result of tenosynovitis and enthesopathy 12 and can be associated with paresthesia of the overlying skin 13 . In most cases of CHIKV infection, patients develop symmetrical oligo or polyarthralgia following the initial onset of fever 14 .
While any joint can be affected, those that are most commonly reported are the distal extremities such as wrists, metacarpal and interphalangeal joints, as well as the ankles and meta-tarsophalangeal joints, though some studies have indicated that the knee is also commonly affected joint 10, 12, 15 . But, in our study most commonly affected joints were ankle joint, knee joint, wrist joint. (Table-2) Sebastian study shows, in the acute stages of the disease, results of a complete blood cell count can be variable, though leukopenia, often as a result of lymphopenia, is one of the most common presentations 16 . This will often persist for the first week of infection, and is occasionally accompanied by thrombocytopenia and an increased hematocrit. Our study population were also consistent with this result and in most cases these parameters returned to normal in the second week of infection. Though a one case developed persistent pancytopenia who required blood transfusion and GM-CSF injection. In our study, blood chemistry results were often normal throughout the disease course, though increased liver enzymes including ALT and AST have been reported. 19 Their study shows arrhythmia occurred in 45 % cases, among them 33 % were bradycardia and others were VPC, tachy-arrhythmia. Serial ECG evaluation remains best guide for the prognosis. 20 A wide array of skin and mucus membrane lesion have been documented in literature by Indian worker during their epidemic of diseases. 21, 22 In their study ,hyperpigmentation in chikungunya fever may be of different types including centro facial, diffuse pigmentation of face, extrimities and pigmentation of existing acne lesion. In our study, two patients developed hyperpigmentation. One male patient had diffuse pigmentation of whole body and in another female patient developed hyperpigmentation in extensor surface of forearm. Female patient's rash worsened into violaceous, vasculitic lesion over the extrimities and subsequently clinically diagnosed as a case of post chikungunya vasculitis. CHIKV can be a rare cause of vasculitis.
Currently, specific treatment modalities for acute and chronic CHIKV-induced disease do not exist, and the majority of treatment plans consist of supportive and symptomatic care. In acute stages of the disease, this consists predominantly of rest, antipyretics and analgesics 11 . In our study, most of the patients were managed with paracetamol, cold compression of joints according to national guideline published by IEDCR (Institute of Epidemiology, Disease control and research). 158 patients (62.45%) required NSAIDs. Patients of chronic kidney disease were managed with colchicine and few required short term oral steroid. We also observed that bed rest was the main stay of treatment. Patients who were admitted in early phase of the diseases got early recovery due to adequate bed rest.
NSAIDs can have variable effects in chronic cases. In one study in Bangladesh, 2 of 6 patients treated acutely with NSAIDs had persistent pain at 2-3 months 9 . In some cases joint pain may resolve, but stiffness remains 23 , perhaps suggesting permanent alterations in articular or peri-articular tissues resulting in decreased mobility. It should also be noted that aspirin is not recommended due to bleeding risk 24 .
Simon et al study 25 , refractory to NSAID treatment cases, short-term courses of corticosteroids have been attempted with variable success. While corticosteroid treatments are usually not recommended due to the potential for a severe rebound of arthritis and tenosynovitis after therapy is ended, in severe cases of inflammatory polyarthritis refractory to NSAID treatment, the benefits may outweigh the risks. In Waymouth study cases, steroids helped resolve symptoms of arthralgia, tenosynovitis, entrapment syndrome and Raynaud's syndrome 8 , while in Foissac cases, they had no effect 14 .
The efficacy of specific antiviral medications are also unknown, though in vitro studies have demonstrated potential utility of ribavirin against alphaviruses in Burt F.J study 26 . In a small cohort of ten patients, decreased pain and swelling were reported in most patients 27 . However, larger scale, controlled efficacy studies have not been performed to assess the true clinical utility of ribavirin in treating CHIKV-induced disease. In our study, we did not treat any patients with anti viral therapy.
While there have been millions of people affected by CHIKV within the last decade, methods of prevention and treatment are still lacking. Preventive measures focus on the mosquito vector and include recommendations such as wearing long sleeves, making use of mosquito nets, elimination of mosquito breeding sites and use of insecticides. Several vaccines are in various stages of development, though none are yet commercially available. 28
Conclusion:
Persistent and disabling arthralgia was a frequent concern of patients who had experienced severe chikungunya virus infection. Treatments are generally symptomatic and supportive, and the efficacies of potentially more specific therapies are currently unknown .Further long term studies are needed to evaluate the prevalence of persistent arthralgia in the general population to determine the real burden of the disease.
